Agenus Inc

+0.12 (+2.32%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.18B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$20.41 Million
Adjusted EPS-$0.24
See more estimates
10-Day MA$5.31
50-Day MA$5.09
200-Day MA$3.92
See more pivots

Agenus Inc Stock, NASDAQ:AGEN

3 Forbes Road, Lexington, Massachusetts 02421-7305
United States of America
Phone: +1.781.674.4400
Number of Employees: 359


Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 31, 1994 and is headquartered in Lexington, MA.